The Weekly Pulse — Edition 22 · February 22, 2026

Published · Researched 2026-09-22

The week in one paragraph

A vaccine is doing the unthinkable in the places that needed it most. Malaria shots have now entered routine immunization in more than 20 African countries, and the world's first full vaccination round inside a refugee camp — 2,100 children under five in Kule camp, Ethiopia, getting their final R21 dose in November 2025 — was followed by close to 50% fewer malaria deaths at the camp hospital in 2025 than in 2024. The researchers are careful: bed nets, spraying, and preventive treatment ran alongside the vaccine, so the drop is not the vaccine's alone. Still, deaths halved where a malaria vaccine had never reached before. Uganda's campaign reached 1.1 million children under two; Zambia became the 24th country to introduce the shot. Still watching: the headline 24M+ dose figure comes from a secondary tracker, not WHO directly, and a Threads post credits a Malaria Consortium analysis for Burkina Faso's steepest single-year drop in under-five deaths — not yet verified against the primary analysis.

Rising

• Europe's birds are setting records. The northern bald ibis — extinct in Central Europe for 300 years — posted a record 2026 breeding season: 29 pairs in Austria and Germany, 21 more in Italy and Switzerland, plus 31 hand-raised juveniles. In Bulgaria, Dalmatian pelicans hit 171 breeding pairs, a national record since monitoring began in 1955, and the Bulgarian Society for the Protection of Birds took home a national Excellence Award for the work.
• A gene-therapy gel for butterfly skin. The FDA approved Vyjuvek back in May 2023, the first redosable gene therapy: a topical gel applied during routine dressing changes that closed 65% of wounds at six months versus 26% with placebo in the Phase 3 GEM-3 trial, with no treatment-related serious adverse events reported. A disease that left children bandaged like burn victims now has something families can actively heal. Still watching: direct social posts about the therapy have not surfaced — the social layer so far is health media.
• Twenty-two dollars becomes a hundred thousand. Rowan Rieve, a 12-year-old from metro Atlanta in treatment for brain tumors since age 8, raised $22.25 at a lemonade stand after hearing about federal research cuts and gave it to his hospital for other kids. His neuro-oncologist shared the story, strangers began donating $22.25 in his honor, and an anonymous donor gave $100,000. The hospital named a room for him.

Falling

• "Untreatable" is losing its grip. Butterfly-skin disease had no treatment at all — now a home-applied gel heals two-thirds of wounds. And malaria vaccination inside refugee camps, once a logistical impossibility, is done and documented.

Quiet signals

• Ibis fledging totals from the record pairs have not been published yet — breeding records are one thing, fledgling survival is the follow-up to watch.
• The pelican colony-by-colony breakdown is not published either; the record is real, the details are pending.
• Rowan's story has soft edges. The anonymous donor's identity was never published and his current health status was not captured — the generosity is verified, the rest stays private.

Scoreboard

N/A — editions are being written out of sequence, so there are no prior calls to grade.

One line to close

The week's two biggest wins — a vaccine in a refugee camp, a gel in a medicine cabinet — share a theme: the help arrived where it was hardest to reach.